Within this framework, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), originally developed for the treatment of type 2 diabetes (T2D), have recently shown cardioprotective effects beyond their role in glycaemic control
[91] [92] While it was previously banned in Western Australia, the Western Australian Health Department lifted the ban in February 2017, bringing Western Australia "into line with other States" where it has always remained legal, albeit closely regulated
Kannan, Maliakal B
Administer by injection as prescribed
Certain herbs, traditionally used in Ayurveda, may support the bodys own GLP-1 production in a gentler, more holistic way
Chen Y, Peng X, Feng Z, Zhang L, Bai J, Li Y, et al